**Hemant Surgical Industries Limited (HSIL)**, established in **1985**, is a **BSE SME Listed** healthcare enterprise. The company has evolved from a specialized importer of wound dressings and hemodialysis products into a vertically integrated powerhouse engaged in the **manufacturing, assembling, importing, and global marketing** of medical equipment and disposables. HSIL operates across a single, comprehensive operating segment, providing end-to-end solutions for the modern healthcare infrastructure. --- ### **Core Business Verticals & Specialized Product Portfolio** HSIL maintains a diverse portfolio across high-growth medical fields, leveraging both indigenous manufacturing and global technical collaborations. | Vertical | Key Products & Equipment | | :--- | :--- | | **Renal Care (Dialysis)** | **SWS 4000A** machines, refurbished units, **RO Plants**, Dialyzers, Bloodline tubing, AV Fistula, and consumables (Heparin, Iron Sucrose, Bicarbonate mixture). | | **Radiology & Imaging** | Indigenously manufactured **Portable X-Ray** and **C-Arm** systems, Digital X-ray imaging panels, and Ultrasound machines. | | **Critical Care** | ICU Ventilators, Anesthesia machines, **Aero** oxygen concentrators, Multi-para monitors, and nebulizers. | | **Surgical Disposables** | **JMS Meditape**, **SafeCath** silicone catheters, skin staplers, IV infusion sets, and wound dressings. | | **Ophthalmology** | High-end operating microscopes (**Takagi**), Slit lamps, Surgical cameras, and specialized Loupes (Galilean, Prismatic, TTL). | | **Cardiology** | Currently importing equipment with a strategic roadmap to develop a **full domestic cardiology product line**. | --- ### **Manufacturing Infrastructure & 'Make in India' Localization** The company is aggressively transitioning from an import-heavy model to **100% localization** through four specialized units in Maharashtra. * **Unit I (Achad Industrial Estate):** Focuses on the production of Dialysis solutions, Sterilants, and Purified water. * **Unit II (Atgaon):** Dedicated to the assembly of 'Aero Plus' brand devices (Nebulizers, Oximeters) and 'Safecath' catheters. * **Unit III (Bhiwandi):** Assembly hub for IV sets, ECG/Ultrasound machines, and Ventilators. * **AURIC Smart City Facility (Sambhaji Nagar):** A new **100,000 Sq Ft** advanced factory nearing completion. It features **Fanuc Japan** machinery for the localization of **JMS Meditape**. This facility benefits from an **80% government project subsidy** and strategic proximity to the Samruddhi Mahamarg. * **R&D Centre:** A dedicated facility focused on dental materials, oral care formulations, and product stability to ensure regulatory alignment for new launches. --- ### **Strategic Partnerships & Global Alliances** HSIL leverages technical collaborations with global technology leaders to facilitate technology transfer and domestic production: * **JMS Co. Ltd (Japan/Singapore):** Technical collaboration for manufacturing medical tapes and wound dressings. * **SWS (China):** Partnership for dialysis machines and consumables. * **Zoncare (China):** Exclusive agreement for ECG channels and ultrasound systems, including the production of **SmartBeat** (WIFI cloud-based ECG). * **Sonomed Escalon (USA):** Strategic **Semi Knocked Down (SKD)** manufacturing agreement for ophthalmic diagnostic imaging (effective March 2026). * **Pixxgen & Remedi (Korea):** Collaboration for digital X-ray imaging panels and portable radiology cameras. --- ### **Turnkey Healthcare Services & Global Expansion** Beyond product sales, HSIL provides **Turnkey Setup Services** for specialized medical facilities, including **Modular Operation Theaters (MOT)**, **Modular ICUs**, and specialized labs (Oncology, Blood Banks, Dental). **International Footprint:** * **Dialysis Centers:** Operates a facility in **Santa Rita, Philippines**, with two additional centers commissioned for late 2024/early 2025. * **Global Offices:** Established entities in **Uganda, Kenya, Tanzania, and the Philippines**, with future hubs planned for **Dubai (UAE)** and the **USA**. * **Digital Transformation:** Launching a B2B eCommerce marketplace for medical consumables to serve domestic and global third-party manufacturers. --- ### **Financial Performance & Capital Structure** HSIL has demonstrated a trajectory of growth, supported by significant capital infusions to fund its manufacturing shift. **Comparative Financial Summary:** | Metric (₹ in Crore) | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | | :--- | :--- | :--- | :--- | :--- | | **Gross Revenue** | - | - | **111.50** | **105.77** | | **Profit Before Tax (PBT)** | **10.56** | **12.78** | **10.06** | **3.40** | | **Net Profit (PAT)** | **8.13** | **9.80** | **7.64** | **2.72** | **Capital Raise & Utilization:** * **Preferential Issue (2025):** Raised **₹92.59 Crores** (including warrants) at an issue price of **₹197** per share. * **IPO Proceeds:** **₹24.84 Crore** raised previously to fuel initial expansion. * **Share Capital:** Authorized capital increased to **₹16.00 Crore** in 2025. * **Debt Profile:** Secured facilities through **Bank of Baroda (₹17.24 Cr sanctioned)** and **SIDBI**, backed by personal guarantees from promoters and mortgages on assets in Mumbai and Aurangabad. --- ### **Order Book & Government Contracts** The company has secured high-value rate contracts, particularly with the **Central Medical Service Society (CMSS)** and state governments: * **Feb 2026 Target:** **₹264.33 Crore** contract for Flat Panel Detectors. * **Sep 2025 Target:** **₹82.89 Crore** contract for Ultraportable Handheld X-ray Machines. * **Bihar Government:** Secured a major contract for **43 Ultrasound Machines**, **700 Multi Para Monitors**, and **112 ECG Machines**. --- ### **Risk Factors & Mitigation** * **Industrial Accident:** A fire at the **Sonale unit** in September 2024 resulted in a **₹5.05 Crore** gross loss. While **₹1.93 Crore** was recovered via insurance, the company absorbed a **₹3.12 Crore net impact** due to uninsured assets (Solar Panels/AHU). * **Legal Disputes:** A pending **Supreme Court** appeal regarding a **₹3.56 Crore** customs dispute over the classification of surgical tapes. * **Regulatory Compliance:** The company has resolved prior **SEBI** non-compliance regarding the **Structured Digital Database (SDD)** and is now fully compliant with Insider Trading regulations. * **Market Competition:** Faces pricing pressure from both organized and unorganized players; mitigated by **ISO 13485** and **CDSCO** certifications and a 24x7 technical support model. * **Concentration Risk:** As a single-segment player, HSIL is diversifying its product range (92+ new registrations) to mitigate industry-specific volatility.